Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ABVC BIOPHARMA, INC.

Get SEC filing alerts via email and in your feed for ABVC BIOPHARMA, INC.

ABVC

ABVC BIOPHARMA, INC.

About ABVC BIOPHARMA, INC.

ABVC BioPharma, Inc. is an early-stage biotechnology company focused on developing innovative botanical drugs for central nervous system and oncology diseases. With a pipeline of seven drug candidates and one medical device, ABVC targets significant unmet medical needs. The company is expanding its market presence through strategic partnerships and clinical trials in the U.S., Taiwan, and Australia, while also leveraging its GMP manufacturing capabilities for drug development.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ABVC BIOPHARMA, INC.

1
1
ABVC BIOPHARMA, INC. ABVC BioPharma Reports $1.69 Million Net Loss in Q1 2026, No Revenue Generated

Via official filing (AI summary) | 17 days ago | 0 comments

2
1
ABVC BIOPHARMA, INC. ABVC Biopharma Reports No Revenue and Increased Losses for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
ABVC BIOPHARMA, INC. ABVC BioPharma Reports 104% Revenue Growth but Faces Increased Net Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ABVC BIOPHARMA, INC. ABVC BioPharma Reports No Revenue and $3.3 Million Net Loss for First Half of 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ABVC BIOPHARMA, INC. ABVC BioPharma Reports Reduced Net Loss and Increased Total Assets in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ABVC BIOPHARMA, INC. ABVC BioPharma Reports 234% Revenue Increase to $509,589 for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ABVC BIOPHARMA, INC. ABVC BioPharma Reports 2,351% Revenue Growth, Net Loss Reduction in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments